Rotor-Gene Q MDx - 40 cycles in 45 min with the QIAGEN RG Kits (assay dependent) Rotor-Gene Q MDx - temperature range, 35☌ to 99☌ (95☏ to 210.2☏) temperature accuracy, ☐.5☌ temperature resolution, ☐.02☌ (smallest programmable increment) temperature uniformity, ☐.02☌ (standard deviation) QIAsymphony SP - purification of bacterial nucleic acids from a variety of starting materials QIAsymphony AS - PCR setup Rotor-Gene Q MDx - qualitative detection of toxigenic C. Protocols/main application on this instrument difficile QS-RGQ MDx Kit Rotor-Gene Q MDx - artus C. QIAsymphony SP - QIAsymphony DSP Virus/Pathogen Kits QIAsymphony AS - artus C. Kits or Application Packs designed for this instrument QIAsymphony SP/AS - 100–240 V AC, 50–60 Hz, 1400 VA, mains supply voltage are not to exceed 10% of nominal supply voltages Rotor-Gene Q MDx - 100–240 V AC, 50–60 Hz, 520 VA (peak) Power consumption 8 VA (standby) Mains supply voltage fluctuations are not to exceed 10% of the nominal supply voltages F5A 250 V fuse QIAsymphony SP - QIAGEN magnetic-particles chemistry Rotor-Gene Q MDx - real-time PCR cycler Rotor-Gene Q MDx - Rotor-Gene Q software 2.1.0 or higher, supplied on the installation CD provided Rotor-Gene AssayManager version 1.0 or higher ![]() Rotor-Gene Q MDx - 6 channels excitation sources: high energy light-emitting diodes detector: photomultiplier acquisition time: 4 seconds QIAsymphony SP/AS - relative humidity of 20–75% (noncondensing) maximum 75% relative humidity Rotor-Gene Q MDx - relative humidity of 10–75% (noncondensing) ![]() QIAsymphony SP/AS - 2 Environmental class 3K2 (IEC 6) 3M2 (IEC 6) Rotor-Gene Q MDx - 2 Environmental class 2K2 (IEC 6) 75% relative humidity (noncondensing) environmental class 1K2 (IEC 6) QIAsymphony SP/AS - 5–40☌ (41✯ to 104✯) in manufacturer's package Rotor-Gene Q MDx - 15 to 30✬ (59✯ to 86✯) in manufacturer’s package max. QIAsymphony SP - 1–96 samples in batches of 24 Rotor-Gene Q MDx - Strip Tubes 0.1 ml (4 tubes) - 72 samples/run This means end users developing new gene-based therapeutics – such as mRNA poly(A) tail length and heterogeneity analysis for mRNA therapeutics and vaccines single guide RNA (sgRNA) characterization for gene editing constructs and mRNA oligo mapping and sequencing – can more quickly develop analytical methods and characterize the nucleic acid components of these drugs and their impurities.QIAsymphony SP/AS - compatible with as many as 4 Rotor-Gene Q MDx instruments Rotor-Gene Q MDx - dynamic range, 10 orders of magnitude ![]() The Waters MaxPeak Premier Oligonucleotide BEH C 18 300Å Columns enable high resolution separation of long-mer oligonucleotides. ![]() New applications associated with nucleic acid therapeutics and vaccines require the ability to separate and analyze long-mer oligonucleotides, which was difficult to achieve with existing column technologies, until now. Oligonucleotide analysis is changing with new modalities demanding more advanced technologies. The columns are available for both UPLC separations with Waters’ ACQUITY Premier Oligonucleotide BEH C 18 columns and UHPLC/HPLC separations with Waters’ XBridge Premier Oligonucleotide BEH C 18 columns. The new columns have all the benefits customers can expect from Waters’ MaxPeak Premier high performance surface chemistry and BEH particle technology – including enhanced sensitivity, reproducibility, and productivity with unmatched pH and temperature stability, which is essential for oligonucleotide/nucleic acid separations. Waters Corp introduces its newest MaxPeak Premier Oligonucleotide Columns – now with ethylene bridged hybrid (BEH) particle technology in 300 Å wide pore versions – to support applications for nucleic acid therapeutics and cell and gene therapies.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |